CEO's open-market purchase at $11.12 signals strong insider conviction ahead of potential upcoming catalysts (pipeline data, regulatory milestones). The historical win rate on KURA bullish calls is 63% at T+20 with +3.78% average return, supporting a positive read-through. Monitor for additional insider buying or pipeline announcements in the coming weeks.
Price Chart
Executive Summary
Kura Oncology CEO Troy Wilson purchased 100,000 shares worth $1.11M on the open market at $11.12/share, representing a material insider conviction buy. This is a strong standalone bullish signal from the highest-ranking insider, particularly notable given the company's $966M market cap and the CEO's direct cash deployment.
Key Financial Metrics
Key Facts
- CEO Troy Wilson purchased 100,000 shares at $11.12/share for total consideration of $1,112,000
- Purchase represents approximately 0.12% of KURA's $966M market cap
- This is the only insider trade in the past 7 days and the only buy in the past 30 days
- CEO is the highest-ranking insider, making this a conviction buy signal
Financial Impact
CEO invested $1.11M of personal capital at $11.12/share, representing ~0.12% of market cap
Risk Factors
- Single insider trade may not reflect broader company outlook
- Biotech sector volatility could overshadow insider signal
- No specific catalyst disclosed alongside the purchase
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001193125-26-354201 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 8-K | $12.09 $11.37 | ▼ −6.00% | ▼ −5.66% | $10.65 (−11.91%) |
Sep 8, 2026 24d ago | 8-K | $12.52 $11.30 | ▼ −9.74% | ▼ −8.63% | $10.65 (−14.94%) |
Aug 24, 2026 5w ago | Insider Cluster | $12.40 $12.65 | ▲ +2.02% | ▲ +1.55% | $10.65 (−14.11%) |
Aug 21, 2026 6w ago | Insider Cluster | $11.89 $12.66 | ▲ +6.48% | ▲ +6.00% | $10.65 (−10.43%) |
Aug 17, 2026 6w ago | Insider Buy | $12.33 $13.59 | ▲ +10.22% | ▲ +10.42% | $10.65 (−13.63%) |
Aug 12, 2026 7w ago | Press Release | $10.09 $11.71 | ▲ +16.06% | ▲ +18.02% | $10.65 (+5.55%) |
Aug 5, 2026 8w ago | Press Release | $9.20 $9.94 | ▲ +8.04% | ▲ +7.69% | $10.65 (+15.76%) |
Jul 29, 2026 9w ago | 8-K | $9.31 $9.28 | ▼ −0.32% | ▼ −3.94% | $10.65 (+14.39%) |
Jul 14, 2026 11w ago | Press Release | $11.24 $10.68 | ▼ −4.98% | ▼ −3.69% | $10.65 (−5.25%) |
Jun 3, 2026 17w ago | Press Release | $8.66 $8.68 | ▲ +0.29% | ▲ +4.11% | $10.65 (+23.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access